Company Filing History:
Years Active: 1990
Title: Raymond E. Mifflin: Innovator in Equine Immunoglobulin Research
Introduction
Raymond E. Mifflin is an accomplished inventor based in Germantown, MD, specializing in advancements in veterinary medicine, particularly in the treatment of foals. With a focus on enhancing maternal immunity transfer in these young horses, Mifflin has made significant contributions to the field through his innovative patent.
Latest Patents
Mifflin holds a patent for "Purified equine immunoglobulins and method of use thereof." This patent details a unique method for recovering equine immunoglobulins from the pass-through fraction of a QAE column loaded with equine serum in an acidic buffer. This process enables the recovery of antibodies that are electrophoretically free of non-immunoglobulin proteins, including transferrin. Importantly, it boasts a higher yield than previously known methods. The purified immunoglobulins are especially beneficial in treating failure of passive transfer of maternal immunity to foals, a critical condition that affects the health of newborn equines.
Career Highlights
Raymond E. Mifflin is associated with Biotech Research Labs, Inc., where he applies his expertise to further research in biotechnology and immunology. His dedication to improving veterinary health has positioned him as a key figure within the biotechnology community.
Collaborations
Throughout his career, Mifflin has likely collaborated with various researchers and institutions in the field of biotechnology, though specific partnerships may not be publicly documented. His work focuses on bridging the gap between scientific research and practical applications in veterinary medicine.
Conclusion
Raymond E. Mifflin's innovative approach to the purification and application of equine immunoglobulins underscores the importance of research in enhancing animal health. His contributions not only benefit the veterinary field but also pave the way for future innovations in the treatment of foals, ensuring better health outcomes for these animals.